Stem Cell Reprogramming

Home

Recent discoveries in the ability to reprogram adult cells without the need for human embryos have generated extreme interest in funding, not only within the United States, but in other countries leading the non-embryonic stem cell research arena, such as Germany and Japan. Because the new method does not require human embryo or embryonic tissues, ethical and moral grounds that have stalled research in the past decade are not apparent. "Being able to have human cells with human disease in a dish accessible for testing is a real boon to technology and to science," says Evan Snyder, director of the Stem Cells and Regeneration Program at the Burnham Institute in La Jolla California.
This new cellular model may allow scientists to research disease processes with extreme accuracy, from the point of its earliest discovery in a cell to the final death of a wide number of tissues and cells. Such research is especially important in the study of such diseases as Alzheimer and Parkinson's disease processes.

Reprogram cells are able to express different genes. These pluripotent cells can develop into any type of cell in the body and can divide indefinitely. Other areas of focus are blood diseases and issues such as anemia as well as treatments for heart disease, muscular dystrophy, and nameless other illnesses, conditions and diseases that have plagued mankind for thousands of years. With stem cell lines developed from a patient, the cells can potentially be reprogrammed to develop into healthy blood and bone tissues.

< Prev		Next >

Through this website you are able to link to other websites which are not under the control of Smart Cells International. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Select country: